Featured Research

from universities, journals, and other organizations

Thymoquinone-induced oxidative stress targets highly aggressive prostate cancers, researchers find

Date:
June 3, 2010
Source:
Society for Experimental Biology and Medicine
Summary:
Researchers have demonstrated that thymoquinone (TQ) a major component of black seed oil (Nigella sativa) can suppress the growth of several aggressive prostate cancer (PCa) cell lines, in vitro. Although previous studies have shown the anti-proliferative effects of TQ in different types of cancers, the molecular mechanism of this effect of TQ had not been delineated.

Researchers at the Tulane University School of Medicine, in New Orleans, LA, have demonstrated that thymoquinone (TQ) a major component of black seed oil (Nigella sativa) can suppress the growth of several aggressive prostate cancer (PCa) cell lines, in vitro.

Related Articles


Although previous studies have shown the anti-proliferative effects of TQ in different types of cancers, the molecular mechanism of this effect of TQ had not been delineated. Since TQ has a structure similar to ubiquinone, a component of the mitochondrial coenzyme-Q (co-Q) complex, the effect of TQ on free oxygen radical production was investigated. These scientists showed exposure to TQ (20-100 ΅mol/L) caused a rapid induction of reactive oxygen species (ROS) generation in both LNCaP and C4-2B cells.

A precipitous decrease in the level of glutathione (GSH) an intracellular small molecule antioxidant was also found to be responsible for the potent anti-cancer effects of TQ which could be inhibited by exogenous addition of N-acetyl cysteine (NAC) a GSH analog. Free oxygen radicals are often used as second messengers for mitogenic signaling in tumor cells where a critical balance in ROS generation and its rapid inactivation by antioxidants, can dictate cell growth or apoptosis. These investigators showed significant increases in several cell death (apoptosis) inducing factors, e.g. GAD45α and AIF-1, in TQ exposed PCa cells.

This study appears in the June 2010 issue of Experimental Biology and Medicine.

Dr. Mondal stated that, "Complementary and alternative medicine (CAM) is becoming very important as an adjunct therapy in cancer patients, both to ameliorate the side effects of chemotherapy as well as to enhance their anti-tumor effects. The low side effect profiles of natural compounds is also an important aspect in their therapeutic utility as an adjunct to anti-tumor therapy. Indeed, in a previous publication (Exp Biol Med; (2009) Apr; 234(4) :442-53) we had shown that at lower concentrations (<5.0 ΅M) TQ decreases ROS production and increases GSH levels in pancreatic beta-cells, which restored nelfinavir (an anti-HIV agent) induced deleterious effects on these cells. Our current findings suggest that the ROS generating effects of high concentrations of TQ (>20 ΅M) may be of great advantage towards the development of novel anti-cancer therapeutics, especially against hormone-refractory prostate cancers which are much harder to treat."

The research team led by Dr. Krishna C. Agrawal (posthumously) included Dr. Sandeep Koka, previously a graduate student under Dr. Agrawal, and two other faculty members from Tulane University, Dr. Asim B. Abdel-Mageed and Dr. Debasis Mondal. These investigators successfully tested the hypothesis that TQ induced oxidative stress is responsible for its anti-proliferative effects in prostate cancer cells. Since black seed oil have been used in the middle eastern countries for hundreds of years, the investigators postulated that the active component TQ and possibly the oil itself, can be used effectively, either alone or as an adjunct to chemotherapy, to target highly aggressive prostate cancers.

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said: "Koka et al. have demonstrated that Thymoquinone efficiently killed hormone-dependent and hormone-independent prostate cancer cells. The mechanism appears to be that Thymoquinone induces oxidative stress and suppresses GSH levels. This suggests that oxidative stress may lead to decreased tumor growth and increased cell death in highly aggressive forms of prostate cancer."


Story Source:

The above story is based on materials provided by Society for Experimental Biology and Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. S. Koka, D. Mondal, M. Schultz, A. B. Abdel-Mageed, K. C. Agrawal. Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species. Experimental Biology and Medicine, 2010; 235 (6): 751 DOI: 10.1258/ebm.2010.009369

Cite This Page:

Society for Experimental Biology and Medicine. "Thymoquinone-induced oxidative stress targets highly aggressive prostate cancers, researchers find." ScienceDaily. ScienceDaily, 3 June 2010. <www.sciencedaily.com/releases/2010/06/100601162256.htm>.
Society for Experimental Biology and Medicine. (2010, June 3). Thymoquinone-induced oxidative stress targets highly aggressive prostate cancers, researchers find. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2010/06/100601162256.htm
Society for Experimental Biology and Medicine. "Thymoquinone-induced oxidative stress targets highly aggressive prostate cancers, researchers find." ScienceDaily. www.sciencedaily.com/releases/2010/06/100601162256.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins